Wednesday, February 8, 2012

Protandim Supplement Anti-Aging Drug Causes Surge in Stock Price for Parent Company Lifevantage Corporation

In less than a 30 day period, the stock price of the Lifevantage Corporation (LFVN) rose by over 19% based on some changes in management and board of directors. The stock which currently resides at about a dollar and a half is still a good buy according to analysts based on the performance of its primary product, Protandim.


Protandim is a dietary supplement which has been clinically proven to reduce the effects of oxidative stress, as well as the progressive rate of cellular aging according to the company. Secondary to the Protandim is LifeVantage TrueScience Anti-Aging Cream.

No comments:

Post a Comment